Antitrust Alliance
  • Home
  • News
  • Antitrust Alliance Publications
  • Members
  • Login
Select Page

Price increases in the pharma sector may be considered abuse of a dominant position

by Andreas Christensen | Apr 21, 2018 | Niet gecategoriseerd

In a recent case, the Danish Competition Council ruled that CD Pharma had abused its dominant position by increasing the price on the medicinal product Syntocinon by 2,000 % in 2014. The decision is the first Danish ruling on excessive pricing in the pharmaceutical sector.
(more…)

Recente berichten

  • Abuse of significant market power – big retail chains is in the focus of the Hungarian Competition Authority
  • French Supreme Court adopts a restrictive interpretation of attorney-client privilege
  • First experiences with the Danish Act on Unfair Food Practices
  • Foreign investment controls: The “foreign investor” test and “protected entity” test in the EU and the UK
  • Prohibition of unfair trade practices in the purchase of agricultural and food products: unilateral modification of contract terms

Recente reacties

No comments to show.
Logo




antitrust-alliance

News

Members

About Us

Login

Website by: 2makeITwork.nl - © Copyright, Antitrust Alliance